In a recent development, Sterigenics and its parent company, Sotera Health, have agreed to a $35 million settlement for cases filed by 79 individuals. These people highlighted that exposure to ethylene oxide (“EtO”) from one of Sterigenics’s medical facilities in the Atlanta region led to their cancer diagnoses and other health complications. Details in the report by Console and Associates, P.C., indicate that the agreement was achieved as the case drew closer to jury selection for what could have been the inaugural trial among several similar EtO exposure and cancer lawsuits in Georgia.
The settlement indicates a significant chapter in legal battles concerning the potential health risks of ethylene oxide exposure. Major corporations and law firms should take particular notice of this settlement and similar cases, as the legal framework around chemical exposure at work continues to evolve.
The Sterigenics case is particularly significant as it was approaching the jury selection phase. Reaching a settlement at this point, particularly a notable amount such as $35 million, highlights the weight of such cases and signals a potential uptick in similar lawsuits moving forward. So, corporations and legal teams must stay ahead of this issue to mitigate legal threats and foster healthy working environments.
With legal battles like these coming to the fore, companies need to rethink and reassess their measures and protocols around chemical exposure. Ethylene Oxide, as seen from the Sterigenics case, can lead to serious health issues including cancer, which could result in serious legal repercussions.
Thus, practicing proactive evaluation of health hazards in the workplace and conducting more comprehensive risk assessments around chemical usage should be a top priority for corporations. Not only will this protect employees, but it can also save businesses from facing potentially costly and reputation-damaging lawsuits like the one Sterigenics and its parent company, Sotera Health, have experienced.